About Hospital General Universitario de Valencia; Servicio de oncologia
Clinical Trials at Hospital General Universitario de Valencia; Servicio de oncologia
During the past decade, Hospital General Universitario de Valencia; Servicio de oncologia conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario de Valencia; Servicio de oncologia"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hospital General Universitario de Valencia; Servicio de oncologia
According to Clinical.Site data, the most researched conditions in "Hospital General Universitario de Valencia; Servicio de oncologia" are
"Basal Cell Carcinoma" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Adenocarcinoma" (1 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Hospital General Universitario de Valencia; Servicio de oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General Universitario de Valencia; Servicio de oncologia
Most popular intervention types in "Hospital General Universitario de Valencia; Servicio de oncologia" are "Drug" (14 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (8 trials), "Cobimetinib" (4 trials), "Vemurafenib" (4 trials), "Paclitaxel" (3 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General Universitario de Valencia; Servicio de oncologia
The vast majority of trials in "Hospital General Universitario de Valencia; Servicio de oncologia" are
14 trials for "All" genders.
Clinical Trials Status at Hospital General Universitario de Valencia; Servicio de oncologia
Currently, there are NaN active trials in "Hospital General Universitario de Valencia; Servicio de oncologia".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Hospital General Universitario de Valencia; Servicio de oncologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General Universitario de Valencia; Servicio de oncologia, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".